European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

European Union - English - EMA (European Medicines Agency)

eisai gmbh - eribulin - breast neoplasms; liposarcoma - antineoplastic agents - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimens for advanced disease (see section 5.1). prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease (see section 5.1).

European Union - English - EMA (European Medicines Agency)

eisai gmbh - bexarotene - lymphoma, t-cell, cutaneous - antineoplastic agents - targretin capsules are indicated for the treatment of skin manifestations of advanced stage cutaneous t-cell lymphoma (ctcl) patients refractory to at least one systemic treatment.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

eisai ltd - eribulin - solution for injection - .44mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

eisai ltd - eribulin - solution for injection - .44mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biogen idec ltd - etanercept - solution for injection - 50mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biogen idec ltd - etanercept - solution for injection - 50mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biogen idec ltd - infliximab - powder for solution for infusion - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biogen idec ltd - etanercept - solution for injection - 50mg/1ml

European Union - English - EMA (European Medicines Agency)

dr. falk pharma gmbh - budesonide - esophageal diseases - antidiarrheals, intestinal antiinflammatory / antiinfective agents - jorveza is indicated for the treatment of eosinophilic esophagitis (eoe) in adults (older than 18 years of age).